Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperandrogenism × Ovidrel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Obesity 2 Hyperandrogenism 1

Interventions

Metformin 7 Progesterone 5 Spironolactone 4 drospirenone and ethinyl estradiol combination 3 Inositol 3 Ethinyl Estradiol 3 salicylsalicylic acid 2 Folic Acid 2 Flutamide 2 Cyproterone Acetate 2 Clomiphene 2 maltodextrin 1 licogliflozin 1 bicalutamide 1 Yoga 1 Topiramate 1 Thioctic Acid 1 Sugars 1 Sodium Salicylate 1 Phlebotomy 1 Ovidrel 1 Magnesium 1 Lactalbumin 1 Inulin 1 Estradiol 1 Dexamethasone 1 Cyproterone acetate, ethinyl estradiol drug combination 1 Carnitine 1 Bloodletting 1 Blood Donation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡